IQVIA Holdings Inc
IQV220.880USD
+2.350+1.08%
Fechamento 11/12, 16:00（ET）Cotações atrasadas em 15 min
37.62BValor de mercado
29.32P/L TTM
Mais detalhes de IQVIA Holdings Inc Empresa
IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.
Informações de IQVIA Holdings Inc
Código da empresaIQV
Nome da EmpresaIQVIA Holdings Inc
Data de listagemMay 09, 2013
CEOMr. Ari Bousbib
Número de funcionários88000
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 09
Endereço2400 Ellis Road
CidadeDURHAM
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal27703
Telefone19199982000
Sitehttps://ir.iqvia.com/
Código da empresaIQV
Data de listagemMay 09, 2013
CEOMr. Ari Bousbib
Executivos da empresa IQVIA Holdings Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
7.01K
+17.56%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
2.74K
+157.67%
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
--
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
863.00
-8.87%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
Americas
1.94B
48.17%
Europe & Africa Region
1.24B
30.89%
Asia Pacific Region
841.00M
20.94%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sex, 31 de out
Atualizado em: sex, 31 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.40%
Harris Associates L.P.
6.90%
BlackRock Institutional Trust Company, N.A.
5.50%
State Street Investment Management (US)
4.48%
GIC Private Limited
3.84%
Outro
67.88%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.40%
Harris Associates L.P.
6.90%
BlackRock Institutional Trust Company, N.A.
5.50%
State Street Investment Management (US)
4.48%
GIC Private Limited
3.84%
Outro
67.88%
Tipos de investidores
Investidores
Proporção
Investment Advisor
48.20%
Investment Advisor/Hedge Fund
34.87%
Hedge Fund
7.16%
Sovereign Wealth Fund
4.96%
Pension Fund
4.16%
Research Firm
2.49%
Bank and Trust
2.06%
Individual Investor
0.91%
Family Office
0.13%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
2061
175.98M
103.33%
-829.63K
2025Q2
2053
166.70M
98.05%
-9.45M
2025Q1
2083
168.53M
97.38%
-9.36M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
2023Q3
1925
170.01M
92.82%
-4.41M
2023Q2
1898
167.84M
91.62%
-8.26M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
19.60M
11.53%
-162.29K
-0.82%
Jun 30, 2025
Harris Associates L.P.
11.75M
6.91%
+583.80K
+5.23%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.37M
5.51%
-507.18K
-5.13%
Jun 30, 2025
State Street Investment Management (US)
7.62M
4.49%
-98.36K
-1.27%
Jun 30, 2025
GIC Private Limited
6.54M
3.85%
-2.59M
-28.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.22M
2.48%
-16.90K
-0.40%
Jun 30, 2025
CPP Investments
4.17M
2.45%
-426.35K
-9.28%
Jun 30, 2025
Farallon Capital Management, L.L.C.
3.85M
2.27%
+439.50K
+12.88%
Jun 30, 2025
AllianceBernstein L.P.
3.56M
2.09%
+19.57K
+0.55%
Jun 30, 2025
Artisan Partners Limited Partnership
3.27M
1.93%
+3.27M
--
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
First Trust Nasdaq Lux Digi Health Solutions ETF
7.97%
Global X HealthTech ETF
5.5%
VanEck Biotech ETF
4.63%
Langar Global HealthTech ETF
4.46%
Adaptive Core ETF
3.04%
iShares Biotechnology ETF
3.03%
iShares ESG Aware MSCI USA Value ETF
2.37%
Invesco Bloomberg Pricing Power ETF
1.96%
American Century Focused Large Cap Value ETF
1.93%
Running Oak Efficient Growth ETF
1.87%
Ver Mais
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção7.97%
Global X HealthTech ETF
Proporção5.5%
VanEck Biotech ETF
Proporção4.63%
Langar Global HealthTech ETF
Proporção4.46%
Adaptive Core ETF
Proporção3.04%
iShares Biotechnology ETF
Proporção3.03%
iShares ESG Aware MSCI USA Value ETF
Proporção2.37%
Invesco Bloomberg Pricing Power ETF
Proporção1.96%
American Century Focused Large Cap Value ETF
Proporção1.93%
Running Oak Efficient Growth ETF
Proporção1.87%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
